nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—Blood uric acid increased—Methotrexate—bone cancer	0.00637	0.00644	CcSEcCtD
Trospium—Hyperuricaemia—Epirubicin—bone cancer	0.00632	0.00638	CcSEcCtD
Trospium—Delirium—Doxorubicin—bone cancer	0.0063	0.00637	CcSEcCtD
Trospium—Stomatitis—Cisplatin—bone cancer	0.00622	0.00629	CcSEcCtD
Trospium—Blood uric acid increased—Epirubicin—bone cancer	0.00597	0.00603	CcSEcCtD
Trospium—Hyperuricaemia—Doxorubicin—bone cancer	0.00584	0.00591	CcSEcCtD
Trospium—Dermatitis contact—Epirubicin—bone cancer	0.00579	0.00585	CcSEcCtD
Trospium—Influenza like illness—Epirubicin—bone cancer	0.00569	0.00575	CcSEcCtD
Trospium—Bladder pain—Methotrexate—bone cancer	0.00566	0.00572	CcSEcCtD
Trospium—Mouth ulceration—Methotrexate—bone cancer	0.00566	0.00572	CcSEcCtD
Trospium—Urinary tract disorder—Cisplatin—bone cancer	0.00566	0.00572	CcSEcCtD
Trospium—Connective tissue disorder—Cisplatin—bone cancer	0.00563	0.00569	CcSEcCtD
Trospium—Urethral disorder—Cisplatin—bone cancer	0.00562	0.00568	CcSEcCtD
Trospium—Fluid retention—Epirubicin—bone cancer	0.00556	0.00562	CcSEcCtD
Trospium—Visual impairment—Cisplatin—bone cancer	0.00552	0.00558	CcSEcCtD
Trospium—Blood uric acid increased—Doxorubicin—bone cancer	0.00552	0.00558	CcSEcCtD
Trospium—Dry eye—Epirubicin—bone cancer	0.00541	0.00547	CcSEcCtD
Trospium—Dermatitis contact—Doxorubicin—bone cancer	0.00536	0.00541	CcSEcCtD
Trospium—Eye disorder—Cisplatin—bone cancer	0.00535	0.00541	CcSEcCtD
Trospium—Lymphadenopathy—Methotrexate—bone cancer	0.00533	0.00538	CcSEcCtD
Trospium—Cardiac disorder—Cisplatin—bone cancer	0.00532	0.00537	CcSEcCtD
Trospium—Flushing—Cisplatin—bone cancer	0.00532	0.00537	CcSEcCtD
Trospium—Mouth ulceration—Epirubicin—bone cancer	0.0053	0.00535	CcSEcCtD
Trospium—Bladder pain—Epirubicin—bone cancer	0.0053	0.00535	CcSEcCtD
Trospium—Influenza like illness—Doxorubicin—bone cancer	0.00526	0.00532	CcSEcCtD
Trospium—Mediastinal disorder—Cisplatin—bone cancer	0.00516	0.00522	CcSEcCtD
Trospium—Fluid retention—Doxorubicin—bone cancer	0.00515	0.0052	CcSEcCtD
Trospium—Abnormal vision—Epirubicin—bone cancer	0.00511	0.00516	CcSEcCtD
Trospium—Dry eye—Doxorubicin—bone cancer	0.00501	0.00506	CcSEcCtD
Trospium—Malnutrition—Cisplatin—bone cancer	0.00499	0.00504	CcSEcCtD
Trospium—Lymphadenopathy—Epirubicin—bone cancer	0.00498	0.00504	CcSEcCtD
Trospium—Flatulence—Cisplatin—bone cancer	0.00491	0.00497	CcSEcCtD
Trospium—Mouth ulceration—Doxorubicin—bone cancer	0.0049	0.00495	CcSEcCtD
Trospium—Bladder pain—Doxorubicin—bone cancer	0.0049	0.00495	CcSEcCtD
Trospium—Muscle spasms—Cisplatin—bone cancer	0.00479	0.00485	CcSEcCtD
Trospium—Eczema—Epirubicin—bone cancer	0.00473	0.00478	CcSEcCtD
Trospium—Abnormal vision—Doxorubicin—bone cancer	0.00473	0.00478	CcSEcCtD
Trospium—Eye pain—Epirubicin—bone cancer	0.00471	0.00476	CcSEcCtD
Trospium—Vision blurred—Cisplatin—bone cancer	0.0047	0.00475	CcSEcCtD
Trospium—Lymphadenopathy—Doxorubicin—bone cancer	0.00461	0.00466	CcSEcCtD
Trospium—Ipratropium bromide—CYP3A4—bone cancer	0.00457	0.429	CrCbGaD
Trospium—Hot flush—Epirubicin—bone cancer	0.00455	0.00459	CcSEcCtD
Trospium—Menopausal symptoms—Epirubicin—bone cancer	0.00451	0.00456	CcSEcCtD
Trospium—Eczema—Doxorubicin—bone cancer	0.00438	0.00443	CcSEcCtD
Trospium—Eye pain—Doxorubicin—bone cancer	0.00436	0.00441	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00422	0.00426	CcSEcCtD
Trospium—Darifenacin—CYP3A4—bone cancer	0.00421	0.396	CrCbGaD
Trospium—Hot flush—Doxorubicin—bone cancer	0.00421	0.00425	CcSEcCtD
Trospium—Migraine—Epirubicin—bone cancer	0.00419	0.00423	CcSEcCtD
Trospium—Menopausal symptoms—Doxorubicin—bone cancer	0.00417	0.00421	CcSEcCtD
Trospium—Breast disorder—Methotrexate—bone cancer	0.00411	0.00415	CcSEcCtD
Trospium—Anaphylactic shock—Cisplatin—bone cancer	0.00407	0.00411	CcSEcCtD
Trospium—Oedema—Cisplatin—bone cancer	0.00407	0.00411	CcSEcCtD
Trospium—Infection—Cisplatin—bone cancer	0.00404	0.00409	CcSEcCtD
Trospium—Nervous system disorder—Cisplatin—bone cancer	0.00399	0.00403	CcSEcCtD
Trospium—Tachycardia—Cisplatin—bone cancer	0.00397	0.00402	CcSEcCtD
Trospium—Skin disorder—Cisplatin—bone cancer	0.00395	0.004	CcSEcCtD
Trospium—Hyperhidrosis—Cisplatin—bone cancer	0.00393	0.00398	CcSEcCtD
Trospium—Dry skin—Epirubicin—bone cancer	0.0039	0.00394	CcSEcCtD
Trospium—Orthostatic hypotension—Epirubicin—bone cancer	0.00388	0.00393	CcSEcCtD
Trospium—Abdominal pain upper—Epirubicin—bone cancer	0.00388	0.00393	CcSEcCtD
Trospium—Migraine—Doxorubicin—bone cancer	0.00387	0.00391	CcSEcCtD
Trospium—Breast disorder—Epirubicin—bone cancer	0.00384	0.00388	CcSEcCtD
Trospium—Nasopharyngitis—Epirubicin—bone cancer	0.0038	0.00384	CcSEcCtD
Trospium—Abdominal discomfort—Methotrexate—bone cancer	0.00377	0.00381	CcSEcCtD
Trospium—Gastritis—Epirubicin—bone cancer	0.00376	0.0038	CcSEcCtD
Trospium—Abdominal distension—Epirubicin—bone cancer	0.0037	0.00374	CcSEcCtD
Trospium—Influenza—Epirubicin—bone cancer	0.00368	0.00372	CcSEcCtD
Trospium—Dysuria—Methotrexate—bone cancer	0.00367	0.00371	CcSEcCtD
Trospium—Dry skin—Doxorubicin—bone cancer	0.00361	0.00365	CcSEcCtD
Trospium—Orthostatic hypotension—Doxorubicin—bone cancer	0.00359	0.00363	CcSEcCtD
Trospium—Abdominal pain upper—Doxorubicin—bone cancer	0.00359	0.00363	CcSEcCtD
Trospium—Photosensitivity reaction—Methotrexate—bone cancer	0.00358	0.00362	CcSEcCtD
Trospium—Angina pectoris—Epirubicin—bone cancer	0.00358	0.00362	CcSEcCtD
Trospium—Breast disorder—Doxorubicin—bone cancer	0.00356	0.00359	CcSEcCtD
Trospium—Decreased appetite—Cisplatin—bone cancer	0.00354	0.00358	CcSEcCtD
Trospium—Nasopharyngitis—Doxorubicin—bone cancer	0.00352	0.00356	CcSEcCtD
Trospium—Gastrointestinal disorder—Cisplatin—bone cancer	0.00351	0.00355	CcSEcCtD
Trospium—Infestation NOS—Methotrexate—bone cancer	0.0035	0.00354	CcSEcCtD
Trospium—Infestation—Methotrexate—bone cancer	0.0035	0.00354	CcSEcCtD
Trospium—Gastritis—Doxorubicin—bone cancer	0.00348	0.00352	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00347	0.00351	CcSEcCtD
Trospium—Dysuria—Epirubicin—bone cancer	0.00344	0.00347	CcSEcCtD
Trospium—Abdominal distension—Doxorubicin—bone cancer	0.00342	0.00346	CcSEcCtD
Trospium—Stomatitis—Methotrexate—bone cancer	0.00341	0.00345	CcSEcCtD
Trospium—Influenza—Doxorubicin—bone cancer	0.0034	0.00344	CcSEcCtD
Trospium—Pollakiuria—Epirubicin—bone cancer	0.0034	0.00343	CcSEcCtD
Trospium—Photosensitivity reaction—Epirubicin—bone cancer	0.00335	0.00339	CcSEcCtD
Trospium—Feeling abnormal—Cisplatin—bone cancer	0.00335	0.00339	CcSEcCtD
Trospium—Weight increased—Epirubicin—bone cancer	0.00334	0.00338	CcSEcCtD
Trospium—Haematuria—Methotrexate—bone cancer	0.00334	0.00337	CcSEcCtD
Trospium—Angina pectoris—Doxorubicin—bone cancer	0.00331	0.00335	CcSEcCtD
Trospium—Infestation NOS—Epirubicin—bone cancer	0.00328	0.00331	CcSEcCtD
Trospium—Infestation—Epirubicin—bone cancer	0.00328	0.00331	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00325	0.00328	CcSEcCtD
Trospium—Stomatitis—Epirubicin—bone cancer	0.00319	0.00323	CcSEcCtD
Trospium—Urinary tract infection—Epirubicin—bone cancer	0.00319	0.00322	CcSEcCtD
Trospium—Dysuria—Doxorubicin—bone cancer	0.00318	0.00321	CcSEcCtD
Trospium—Pollakiuria—Doxorubicin—bone cancer	0.00314	0.00318	CcSEcCtD
Trospium—Haematuria—Epirubicin—bone cancer	0.00312	0.00316	CcSEcCtD
Trospium—Urinary tract disorder—Methotrexate—bone cancer	0.0031	0.00314	CcSEcCtD
Trospium—Photosensitivity reaction—Doxorubicin—bone cancer	0.0031	0.00314	CcSEcCtD
Trospium—Weight increased—Doxorubicin—bone cancer	0.0031	0.00313	CcSEcCtD
Trospium—Urethral disorder—Methotrexate—bone cancer	0.00308	0.00311	CcSEcCtD
Trospium—Infestation NOS—Doxorubicin—bone cancer	0.00303	0.00306	CcSEcCtD
Trospium—Infestation—Doxorubicin—bone cancer	0.00303	0.00306	CcSEcCtD
Trospium—Visual impairment—Methotrexate—bone cancer	0.00303	0.00306	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00301	0.00304	CcSEcCtD
Trospium—Erythema multiforme—Methotrexate—bone cancer	0.00297	0.003	CcSEcCtD
Trospium—Stomatitis—Doxorubicin—bone cancer	0.00296	0.00299	CcSEcCtD
Trospium—Rhinitis—Epirubicin—bone cancer	0.00295	0.00298	CcSEcCtD
Trospium—Urinary tract infection—Doxorubicin—bone cancer	0.00295	0.00298	CcSEcCtD
Trospium—Eye disorder—Methotrexate—bone cancer	0.00294	0.00297	CcSEcCtD
Trospium—Asthenia—Cisplatin—bone cancer	0.00292	0.00295	CcSEcCtD
Trospium—Cardiac disorder—Methotrexate—bone cancer	0.00292	0.00295	CcSEcCtD
Trospium—Urinary tract disorder—Epirubicin—bone cancer	0.00291	0.00294	CcSEcCtD
Trospium—Oedema peripheral—Epirubicin—bone cancer	0.0029	0.00293	CcSEcCtD
Trospium—Haematuria—Doxorubicin—bone cancer	0.00289	0.00292	CcSEcCtD
Trospium—Connective tissue disorder—Epirubicin—bone cancer	0.00289	0.00292	CcSEcCtD
Trospium—Urethral disorder—Epirubicin—bone cancer	0.00288	0.00291	CcSEcCtD
Trospium—Angiopathy—Methotrexate—bone cancer	0.00285	0.00288	CcSEcCtD
Trospium—Visual impairment—Epirubicin—bone cancer	0.00284	0.00287	CcSEcCtD
Trospium—Mediastinal disorder—Methotrexate—bone cancer	0.00283	0.00286	CcSEcCtD
Trospium—Erythema multiforme—Epirubicin—bone cancer	0.00278	0.00281	CcSEcCtD
Trospium—Eye disorder—Epirubicin—bone cancer	0.00275	0.00278	CcSEcCtD
Trospium—Malnutrition—Methotrexate—bone cancer	0.00274	0.00277	CcSEcCtD
Trospium—Flushing—Epirubicin—bone cancer	0.00273	0.00276	CcSEcCtD
Trospium—Cardiac disorder—Epirubicin—bone cancer	0.00273	0.00276	CcSEcCtD
Trospium—Rhinitis—Doxorubicin—bone cancer	0.00273	0.00276	CcSEcCtD
Trospium—Urinary tract disorder—Doxorubicin—bone cancer	0.00269	0.00272	CcSEcCtD
Trospium—Oedema peripheral—Doxorubicin—bone cancer	0.00268	0.00271	CcSEcCtD
Trospium—Dysgeusia—Methotrexate—bone cancer	0.00268	0.00271	CcSEcCtD
Trospium—Connective tissue disorder—Doxorubicin—bone cancer	0.00267	0.0027	CcSEcCtD
Trospium—Angiopathy—Epirubicin—bone cancer	0.00267	0.0027	CcSEcCtD
Trospium—Urethral disorder—Doxorubicin—bone cancer	0.00267	0.0027	CcSEcCtD
Trospium—Mediastinal disorder—Epirubicin—bone cancer	0.00265	0.00268	CcSEcCtD
Trospium—Back pain—Methotrexate—bone cancer	0.00265	0.00268	CcSEcCtD
Trospium—Visual impairment—Doxorubicin—bone cancer	0.00262	0.00265	CcSEcCtD
Trospium—Vomiting—Cisplatin—bone cancer	0.00259	0.00262	CcSEcCtD
Trospium—Vision blurred—Methotrexate—bone cancer	0.00258	0.00261	CcSEcCtD
Trospium—Erythema multiforme—Doxorubicin—bone cancer	0.00257	0.0026	CcSEcCtD
Trospium—Rash—Cisplatin—bone cancer	0.00257	0.00259	CcSEcCtD
Trospium—Dermatitis—Cisplatin—bone cancer	0.00256	0.00259	CcSEcCtD
Trospium—Malnutrition—Epirubicin—bone cancer	0.00256	0.00259	CcSEcCtD
Trospium—Eye disorder—Doxorubicin—bone cancer	0.00254	0.00257	CcSEcCtD
Trospium—Flushing—Doxorubicin—bone cancer	0.00253	0.00255	CcSEcCtD
Trospium—Cardiac disorder—Doxorubicin—bone cancer	0.00253	0.00255	CcSEcCtD
Trospium—Flatulence—Epirubicin—bone cancer	0.00252	0.00255	CcSEcCtD
Trospium—Dysgeusia—Epirubicin—bone cancer	0.00251	0.00253	CcSEcCtD
Trospium—Back pain—Epirubicin—bone cancer	0.00248	0.0025	CcSEcCtD
Trospium—Angiopathy—Doxorubicin—bone cancer	0.00247	0.0025	CcSEcCtD
Trospium—Muscle spasms—Epirubicin—bone cancer	0.00246	0.00249	CcSEcCtD
Trospium—Mediastinal disorder—Doxorubicin—bone cancer	0.00245	0.00248	CcSEcCtD
Trospium—Nausea—Cisplatin—bone cancer	0.00242	0.00244	CcSEcCtD
Trospium—Vision blurred—Epirubicin—bone cancer	0.00241	0.00244	CcSEcCtD
Trospium—Malnutrition—Doxorubicin—bone cancer	0.00237	0.0024	CcSEcCtD
Trospium—Flatulence—Doxorubicin—bone cancer	0.00234	0.00236	CcSEcCtD
Trospium—Chest pain—Methotrexate—bone cancer	0.00233	0.00235	CcSEcCtD
Trospium—Dysgeusia—Doxorubicin—bone cancer	0.00232	0.00235	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00231	0.00234	CcSEcCtD
Trospium—Syncope—Epirubicin—bone cancer	0.0023	0.00232	CcSEcCtD
Trospium—Back pain—Doxorubicin—bone cancer	0.00229	0.00232	CcSEcCtD
Trospium—Muscle spasms—Doxorubicin—bone cancer	0.00228	0.0023	CcSEcCtD
Trospium—Palpitations—Epirubicin—bone cancer	0.00226	0.00229	CcSEcCtD
Trospium—Confusional state—Methotrexate—bone cancer	0.00225	0.00228	CcSEcCtD
Trospium—Loss of consciousness—Epirubicin—bone cancer	0.00225	0.00228	CcSEcCtD
Trospium—Anaphylactic shock—Methotrexate—bone cancer	0.00223	0.00226	CcSEcCtD
Trospium—Vision blurred—Doxorubicin—bone cancer	0.00223	0.00226	CcSEcCtD
Trospium—Infection—Methotrexate—bone cancer	0.00222	0.00224	CcSEcCtD
Trospium—Nervous system disorder—Methotrexate—bone cancer	0.00219	0.00221	CcSEcCtD
Trospium—Chest pain—Epirubicin—bone cancer	0.00218	0.0022	CcSEcCtD
Trospium—Skin disorder—Methotrexate—bone cancer	0.00217	0.00219	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00217	0.00219	CcSEcCtD
Trospium—Hyperhidrosis—Methotrexate—bone cancer	0.00216	0.00218	CcSEcCtD
Trospium—Dry mouth—Epirubicin—bone cancer	0.00213	0.00216	CcSEcCtD
Trospium—Syncope—Doxorubicin—bone cancer	0.00213	0.00215	CcSEcCtD
Trospium—Confusional state—Epirubicin—bone cancer	0.00211	0.00213	CcSEcCtD
Trospium—Palpitations—Doxorubicin—bone cancer	0.00209	0.00212	CcSEcCtD
Trospium—Oedema—Epirubicin—bone cancer	0.00209	0.00211	CcSEcCtD
Trospium—Anaphylactic shock—Epirubicin—bone cancer	0.00209	0.00211	CcSEcCtD
Trospium—Loss of consciousness—Doxorubicin—bone cancer	0.00208	0.00211	CcSEcCtD
Trospium—Infection—Epirubicin—bone cancer	0.00208	0.0021	CcSEcCtD
Trospium—Shock—Epirubicin—bone cancer	0.00206	0.00208	CcSEcCtD
Trospium—Nervous system disorder—Epirubicin—bone cancer	0.00205	0.00207	CcSEcCtD
Trospium—Tachycardia—Epirubicin—bone cancer	0.00204	0.00206	CcSEcCtD
Trospium—Skin disorder—Epirubicin—bone cancer	0.00203	0.00205	CcSEcCtD
Trospium—Hyperhidrosis—Epirubicin—bone cancer	0.00202	0.00204	CcSEcCtD
Trospium—Chest pain—Doxorubicin—bone cancer	0.00202	0.00204	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.002	0.00203	CcSEcCtD
Trospium—Somnolence—Methotrexate—bone cancer	0.00199	0.00201	CcSEcCtD
Trospium—Dry mouth—Doxorubicin—bone cancer	0.00197	0.00199	CcSEcCtD
Trospium—Dyspepsia—Methotrexate—bone cancer	0.00197	0.00199	CcSEcCtD
Trospium—Confusional state—Doxorubicin—bone cancer	0.00195	0.00197	CcSEcCtD
Trospium—Decreased appetite—Methotrexate—bone cancer	0.00194	0.00196	CcSEcCtD
Trospium—Oedema—Doxorubicin—bone cancer	0.00193	0.00195	CcSEcCtD
Trospium—Anaphylactic shock—Doxorubicin—bone cancer	0.00193	0.00195	CcSEcCtD
Trospium—Gastrointestinal disorder—Methotrexate—bone cancer	0.00193	0.00195	CcSEcCtD
Trospium—Fatigue—Methotrexate—bone cancer	0.00193	0.00195	CcSEcCtD
Trospium—Infection—Doxorubicin—bone cancer	0.00192	0.00194	CcSEcCtD
Trospium—Shock—Doxorubicin—bone cancer	0.0019	0.00192	CcSEcCtD
Trospium—Nervous system disorder—Doxorubicin—bone cancer	0.0019	0.00192	CcSEcCtD
Trospium—Tachycardia—Doxorubicin—bone cancer	0.00189	0.00191	CcSEcCtD
Trospium—Skin disorder—Doxorubicin—bone cancer	0.00188	0.0019	CcSEcCtD
Trospium—Hyperhidrosis—Doxorubicin—bone cancer	0.00187	0.00189	CcSEcCtD
Trospium—Somnolence—Epirubicin—bone cancer	0.00186	0.00188	CcSEcCtD
Trospium—Methadone—CYP3A4—bone cancer	0.00186	0.174	CrCbGaD
Trospium—Feeling abnormal—Methotrexate—bone cancer	0.00184	0.00186	CcSEcCtD
Trospium—Dyspepsia—Epirubicin—bone cancer	0.00184	0.00186	CcSEcCtD
Trospium—Gastrointestinal pain—Methotrexate—bone cancer	0.00183	0.00185	CcSEcCtD
Trospium—Decreased appetite—Epirubicin—bone cancer	0.00182	0.00184	CcSEcCtD
Trospium—Gastrointestinal disorder—Epirubicin—bone cancer	0.0018	0.00182	CcSEcCtD
Trospium—Fatigue—Epirubicin—bone cancer	0.0018	0.00182	CcSEcCtD
Trospium—Constipation—Epirubicin—bone cancer	0.00179	0.00181	CcSEcCtD
Trospium—Urticaria—Methotrexate—bone cancer	0.00177	0.00179	CcSEcCtD
Trospium—Abdominal pain—Methotrexate—bone cancer	0.00177	0.00178	CcSEcCtD
Trospium—Feeling abnormal—Epirubicin—bone cancer	0.00172	0.00174	CcSEcCtD
Trospium—Somnolence—Doxorubicin—bone cancer	0.00172	0.00174	CcSEcCtD
Trospium—Gastrointestinal pain—Epirubicin—bone cancer	0.00171	0.00173	CcSEcCtD
Trospium—Dyspepsia—Doxorubicin—bone cancer	0.0017	0.00172	CcSEcCtD
Trospium—Decreased appetite—Doxorubicin—bone cancer	0.00168	0.0017	CcSEcCtD
Trospium—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00167	0.00169	CcSEcCtD
Trospium—Fatigue—Doxorubicin—bone cancer	0.00167	0.00169	CcSEcCtD
Trospium—Urticaria—Epirubicin—bone cancer	0.00166	0.00168	CcSEcCtD
Trospium—Constipation—Doxorubicin—bone cancer	0.00165	0.00167	CcSEcCtD
Trospium—Abdominal pain—Epirubicin—bone cancer	0.00165	0.00167	CcSEcCtD
Trospium—Asthenia—Methotrexate—bone cancer	0.0016	0.00162	CcSEcCtD
Trospium—Feeling abnormal—Doxorubicin—bone cancer	0.00159	0.00161	CcSEcCtD
Trospium—Gastrointestinal pain—Doxorubicin—bone cancer	0.00158	0.0016	CcSEcCtD
Trospium—Pruritus—Methotrexate—bone cancer	0.00158	0.0016	CcSEcCtD
Trospium—Urticaria—Doxorubicin—bone cancer	0.00154	0.00155	CcSEcCtD
Trospium—Abdominal pain—Doxorubicin—bone cancer	0.00153	0.00155	CcSEcCtD
Trospium—Asthenia—Epirubicin—bone cancer	0.0015	0.00152	CcSEcCtD
Trospium—Pruritus—Epirubicin—bone cancer	0.00148	0.00149	CcSEcCtD
Trospium—Dizziness—Methotrexate—bone cancer	0.00148	0.00149	CcSEcCtD
Trospium—Vomiting—Methotrexate—bone cancer	0.00142	0.00144	CcSEcCtD
Trospium—Rash—Methotrexate—bone cancer	0.00141	0.00142	CcSEcCtD
Trospium—Dermatitis—Methotrexate—bone cancer	0.00141	0.00142	CcSEcCtD
Trospium—Headache—Methotrexate—bone cancer	0.0014	0.00141	CcSEcCtD
Trospium—Asthenia—Doxorubicin—bone cancer	0.00139	0.0014	CcSEcCtD
Trospium—Dizziness—Epirubicin—bone cancer	0.00138	0.0014	CcSEcCtD
Trospium—Pruritus—Doxorubicin—bone cancer	0.00137	0.00138	CcSEcCtD
Trospium—Vomiting—Epirubicin—bone cancer	0.00133	0.00134	CcSEcCtD
Trospium—Nausea—Methotrexate—bone cancer	0.00133	0.00134	CcSEcCtD
Trospium—Rash—Epirubicin—bone cancer	0.00132	0.00133	CcSEcCtD
Trospium—Dermatitis—Epirubicin—bone cancer	0.00132	0.00133	CcSEcCtD
Trospium—Headache—Epirubicin—bone cancer	0.00131	0.00132	CcSEcCtD
Trospium—Dizziness—Doxorubicin—bone cancer	0.00128	0.00129	CcSEcCtD
Trospium—Nausea—Epirubicin—bone cancer	0.00124	0.00125	CcSEcCtD
Trospium—Vomiting—Doxorubicin—bone cancer	0.00123	0.00124	CcSEcCtD
Trospium—Rash—Doxorubicin—bone cancer	0.00122	0.00123	CcSEcCtD
Trospium—Dermatitis—Doxorubicin—bone cancer	0.00122	0.00123	CcSEcCtD
Trospium—Headache—Doxorubicin—bone cancer	0.00121	0.00122	CcSEcCtD
Trospium—Nausea—Doxorubicin—bone cancer	0.00115	0.00116	CcSEcCtD
